Qiagen, Pfizer Collaborate on Companion Dx for NSCLC
August 16, 2011
Qiagen, Pfizer Collaborate on Companion Dx for NSCLC
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- FDA Clears Abbott's Companion Dx for Pfizer's NSCLC Drug
August 29, 2011 / GenomeWeb Daily News - Arbitration Panel Rules Operon Must Pay Qiagen $2.1M
August 19, 2011 / GenomeWeb Daily News - Big Pharma Exploring Targeted MS to Measure Key Transporter Proteins for Drug Development
August 12, 2011 / ProteoMonitor - Australian Court Approves Qiagen's Purchase of Cellestis Shares
August 10, 2011 / GenomeWeb Daily News - Tohoku U Spinoff Targeting Pharma Industry with SRM-MS Assays for ADMET Research
August 5, 2011 / ProteoMonitor